Blog

TUESDAY, Oct. 17, 2023 (HealthDay News) — The U.S. Food and Drug Administration approved Velsipity (etrasimod) for adults with moderately to severely active ulcerative colitis (UC).The approval was based on results from the ELEVATE UC phase 3 registr…

TUESDAY, Oct. 17, 2023 (HealthDay News) — Relaxing immersive virtual reality (VR) interventions are acceptable and feasible and can offer benefits to patients with cancer, according to a review published online Oct. 16 in BMJ Supportive & Palliative …

TUESDAY, Oct. 17, 2023 (HealthDay News) — Adoption of virtual psychotherapy technology led to fewer disruptions to care than before the COVID-19 pandemic, according to a study published online Oct. 11 in Psychiatric Services.Brian K. Ahmedani, Ph.D.,…

TUESDAY, Oct. 17, 2023 (HealthDay News) — A proposed rule from federal regulators that would ban menthol cigarettes and flavored cigars has been sent to the White House Office of Management and Budget for final review.The U.S. Food and Drug Administr…

TUESDAY, Oct. 17, 2023 (HealthDay News) — Adults with attention-deficit/hyperactivity disorder (ADHD) are nearly three times more likely to develop dementia than other adults, a new study suggests.The results also indicate that treatment with ADHD me…

As climate change warms the planet, extreme heat is becoming more common in the workplace for millions.Many jobs throughout the United States require working in extreme heat, and higher temperatures can cause conditions like heat exhaustion, cramps, f…

TUESDAY, Oct. 17, 2023 (HealthDay News) — Two doses of a novel intranasal live-attenuated COVID-19 vaccine, CoviLiv, induce poly-antigenic immune response, according to a study presented at the annual meeting of the Infectious Diseases Society of Ame…